Histology and Cytology Market: Current Analysis and Forecast (2022-2030)

Histology and Cytology Market: Current Analysis and Forecast (2022-2030)

Histology and cytology are interconnected areas of study that center on examining tissues and cells to detect medical conditions and anomalies. The histology sector focuses on readying, coloring, and scrutinizing samples of tissues to identify ailments like cancer. In contrast, cytology focuses on analyzing individual cells to pinpoint any irregularities or malignant cells.

The Histology And Cytology Market is expected to grow at a strong CAGR of 12.4% during the forecast period owing to the increasing prevalence of cancer and the growing aging population. Moreover, numerous governments worldwide have initiated campaigns to encourage cancer screening and early detection, which is anticipated to fuel the demand for histology and cytology techniques. For example, the US administration has introduced the Early Detection Research Network (EDRN) under the National Cancer Institute to encourage the timely detection of cancer using biomarkers and other diagnostic methods.

• Based on examination type, the histology and cytology market is segmented into histology and cytology (Breast Cancer, Cervical Cancer, and Others). The cytology segment accounted for a significant market share in 2021 and it is estimated to grow rapidly during the projected timeframe. This is mainly owing to cytology tests being widely used for cellular-level observations in the identification of various cancer kinds, such as breast and cervical cancer coupled with the growing popularity of co-testing across the globe. For instance, in Mar 2020, Roche received FDA approval for the CINtec PLUS Cytology test to aid clinicians in improving cervical cancer prevention.
• Based on test type, the histology and cytology market is divided into microscopy tests, molecular genetics tests, and flow cytometry. Among these, microscopy tests will attain a considerable share of the market during the forecast period. Microscopy tests are utilized for the purpose of scrutinizing tissue samples under a microscope to identify irregularities or diagnose diseases. These tests have gained widespread popularity and are considered an established and efficient diagnostic tool that is utilized in numerous medical fields.
• Based on product type, the histology and cytology market is segmented into Instruments & Analysis Software System, and Consumable & Reagents. Among these, consumable and reagents segment accounted for a significant market share in 2021 and estimated to grow rapidly during the forecast period. The rising incidence of cancer and chronic diseases has led to an increase in demand for histology and cytology tests, which in turn has driven the growth of consumables and reagents. In addition, the shift towards personalized medicine has led to an increase in demand for molecular diagnostics and genetic testing, which require a wide range of consumables and reagents.
• Based on end-user, the market is segmented into Hospitals & Clinical Diagnostics, Academic & Research Institutes, and Others. Clinical Diagnostics are expected to grow at a substantial CAGR during the forecasted period. As the application of histopathology studies for diagnosing various types of cancer has been on the rise, the removal of cells and tissues from suspected lumps for the purpose of identifying abnormalities and malignancies has become prevalent. These studies are extensively utilized for the screening of several types of cancer, including breast, bowel, and cervical cancer.
• For a better understanding of the market adoption of the Industrial Relay industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, UK, France, Italy, Spain , Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific), Rest of World. North America is expected to lead the market share owing to the factors such as the increase in the number of research and development activities, product approvals, and commercialization, as well as the prevalence of geriatrics in the area. Additionally, the region has seen a high prevalence of cancer and a rising number of older adults who are affected which in turn increases the growth of the market. According to the American Cancer Society, Inc., the estimated number of new cancer cases and deaths in 2021 (In 2021, there will be an estimated 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the United States.)
• Some of the major players operating in the market include Abbott; BD, Merck KGaA, F. Hoffmann-La Roche Ltd; Hologic, Inc.; Sysmex Corporation; Danaher; Trivitron Healthcare; Thermo Fisher Scientific Inc; Agilent Technologies, Inc.

The histology and cytology market is expected to grow at a strong CAGR of around 12.4% during the forecast period owing to the growing development of advanced technologies such as digital pathology, automation, and next-generation sequencing has led to more accurate and efficient diagnostic testing. Moreover, With the increasing demand for the detection of cell and tissue characteristics and an increase in the occurrence of cell-based disorders like cancer around the world. The advantage of the quick interpretation of primary diagnostic data is provided by the incorporation of digital solutions to the cytological diagnosis. Additionally, businesses are introducing cutting-edge digital cytology devices that will help with the quick on-site screening of cytology samples and further help in better observation in histology testing of the disease. There are many diagnostics that are working to improve technological advancement to better examine the disease. For instance, in June 2021, Antech Diagnostics introduced a Digital Cytology Scanner in North America. This scanner makes it possible to offer whole-slide interpretations in under two hours, which helps shorten examination times and evaluate plenty of samples in POC situations.

Some of the major players operating in the market include Abbott; BD, Merck KGaA, F. Hoffmann-La Roche Ltd; Hologic, Inc.; Sysmex Corporation; Danaher; Trivitron Healthcare; Thermo Fisher Scientific Inc; Agilent Technologies, Inc. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report

“Amongst examination type, the histology segment has a considerable share of the market in 2021.”

Based on examination type, the histology and cytology market are segmented into Histology and Cytology (Breast Cancer, Cervical Cancer, and Others). Amongst these, the histology segment will attain a considerable share of the market during the forecast period. This is because due to the rising geriatric population, increasing research activities, and government initiatives and funding towards healthcare infrastructure, research and development, and cancer screening programs have contributed to the growth of the histology segment.

“Amongst product type, the Instruments & Analysis Software will attain the fastest growth in the market during the forecast period.”

Based on product type, the histology and cytology market are bifurcated into Instruments & Analysis Software System, and Consumable & Reagents. Among these, the instruments & analysis software system segment will attain fastest growth in the market during forecast period owing to the use of advanced tools like multimodal nonlinear microscopy, photoacoustic microscopy, and stimulated Raman spectroscopy for histopathology has been increasing. However, the adoption of large-scale digital solutions in the pathology industry has been hindered by high infrastructure costs and technical limitations.

“North America is expected to lead the market share during the forecast period.”

The North American market for histology and cytology is expanding due to various reasons. One of the main factors driving this growth is the escalating occurrence of chronic illnesses, including cancer, in the region. The American Cancer Society reported approximately 1.8 million new cancer cases in the United States in 2020, making histology and cytology critical tools in diagnosing and treating cancer. Alongside the increased prevalence of cancer, progress in histology and cytology technology has also played a role in the market's expansion. Advancements such as digital pathology solutions and automated tissue processing systems have resulted in faster and more precise processes, which has led to greater adoption of these technologies in North America.

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
• The report presents a quick review of overall industry performance at one glance.
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
• The study comprehensively covers the market across different segments.
• Deep dive regional level analysis of the industry.